A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
The article says to consider whether a different GLP-1 formulation might suit your physiology better, naming oral semaglutide, tirzepatide, or dual-compound protocols such as GLP-Squared
As previously stated, PT-141 is an FDA-approved drug used to treat hypoactive sexual desire disorder (HSDD) and it is also available online as a research chemical to qualified researchers
According to the American Heart Association, gaining 23 lbs over 24 hours, or 5 lbs in a week, could be an early sign of heart failure
Importantly, a consensus on the most clinically relevant primary endpoint needs to be reached to compare the results of different studies